Carlo Incerti - 02 Mar 2022 Form 3 Insider Report for Dyne Therapeutics, Inc. (DYN)

Role
Director
Signature
/s/ Richard Scalzo, Attorney-in-Fact
Issuer symbol
DYN
Transactions as of
02 Mar 2022
Net transactions value
$0
Form type
3
Filing time
04 Mar 2022, 17:21:49 UTC
Next filing
25 May 2023

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.